Lidocaine and Metabolite (MEGX), Serum/Plasma Test (2512SP)

Lidocaine and Metabolite (MEGX), Serum/Plasma Test (2512SP)

Analysis Code 2512SP 
Test Name Lidocaine and Metabolite (MEGX), Serum/Plasma 
Test Includes Lidocaine; Monoethylglycinexylidide (MEGX) 
Compound Synonym(s) Lidocaine Metabolite; Xylocaine┬« 
Purpose Therapeutic Drug Monitoring; This test is New York State approved. 
Category Anesthetic (Local) 
Method(s) Gas Chromatography (GC) 
Specimen Requirements 1 mL Serum or Plasma 
Transport Temperature Refrigerated 
Specimen Container NMS Labs has no experimental or literature-based data regarding the choice of specific specimen collection containers for this test. 
Special Handling Promptly centrifuge and separate Serum or Plasma into a plastic screw capped vial using approved guidelines. 
Light Protection Required Not Required 
Stability Room Temperature: Undetermined
Refrigerated: Undetermined
Frozen (-20 ┬░C): Undetermined 
*Rejection Criteria Polymer gel separation tube (SST or PST). 
Known Interference(s) Lidocaine [GC]: Diphenhydramine 
Day(s) Test Set-up / TAT [GC] Tuesday / 3 days 
Suggested CPT Code 80176 
**Minimum Volume 0.4 mL 
Test Summary Sheet Generate  

You are viewing Lidocaine and Metabolite (MEGX), Serum/Plasma Test (2512SP)
*Rejection criteria pertain to clinical specimen submissions only.
**Stated minimum volume allows for a single analysis. Repeat analysis will not be performed.


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9

Enter your e-mail address if you would like NMS Labs to add this test to the selection of tests that can be purchased by using a credit card versus traditional ordering methods.